Pre-registration for participation in the SERENITY Physician Survey

Current European patterns of deprescribing antithrombotic medication during end-of-life care in cancer patients

Thank you for your interest in this important study!

The insights to be gained in this study are a first step towards the development of a clinical decision tool supporting decisions on antithrombotic medication in cancer patients.

Please follow the link below and read the privacy information carefully before proceeding to pre-registration:

English: Privacy Information, see section “What will happen with my data and will I be informed of the survey results?”
German: Datenschutzinformationen, siehe Abschnitt “Was passiert mit meinen Daten und werde ich über die Umfrageergebnisse informiert?”

In order to notify you of the survey launch, we need to process the following personal data from you (Art. 4 No. 1 GDPR): your e-mail address (and your name, if included in the e-mail address).
By pre-registering you consent to the use of your above data as part of the survey.
Your participation in the survey is voluntary and your pre-registration does not oblige you to take the survey.

I agree to the Terms of Use and acknowledge that I have read the privacy information.

Please enter your e-mail address:

In which country do you practice:

Denmark

France

Germany

Italy

The Netherlands

Poland

Spain

United Kingdom

Other Other

Please select your age category:

25-34 years

35-44 years

45-54 years

55-64 years

65 years or older

Please select your sex:

Male

Female

Other Other

Please select your profession:

General practitioner

Palliative care specialist

Nursing home physician

Geriatrist

Vascular medicine specialist

Oncologist

Haematologist

Pulmonologist

Cardiologist

Neurologist

Vascular surgeon

Other (if applicable, specify the department) Other (if applicable, specify the department)

Please select the professional experience group that matches your years of experience:

< 5 years

5-10 years

11-15 years

16-20 years

21 years or more

Please provide an estimate on the number of patients you see/treat each year with active cancer, who are considered to be in end-of-life care and are on antithrombotic medication.